Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications

Hana Kadavil; Sandi Ali Adib; Alia Marei; Noora H. Al-Qahtani; Ying Zhu; Ali A. Al-Kinani; Raid G. Alany; Husam M. Younes

doi:10.1080/17425247.2025.2516668

Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications

Hana Kadavil
, Sandi Ali Adib
, Alia Marei
, Noora H. Al-Qahtani
, Ying Zhu
, Ali A. Al-Kinani
, Raid G. Alany
, Husam M. Younes

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Expert Opinion on Drug Delivery
Early online date	9 Jun 2025
DOIs	https://doi.org/10.1080/17425247.2025.2516668
Publication status	E-pub ahead of print - 9 Jun 2025

Bibliographical note

Note: This work was supported by the Qatar Research, Development & Innovation (QRDI) National Priorities Research Program (NPRP) [grant # NPRP13S-0126-200173].

Keywords

Biological sciences

Access to Document

10.1080/17425247.2025.2516668

Embargoed Document

Al-Kinani-A-48045516-AAM
Accepted author manuscript, 525 KB
Licence: Other
Embargo ends: 9/06/26

Cite this

Kadavil, H., Ali Adib, S., Marei, A., Al-Qahtani, N. H., Zhu, Y., Al-Kinani, A. A., Alany, R. G., & Younes, H. M. (2025). Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications. Expert Opinion on Drug Delivery. Advance online publication. https://doi.org/10.1080/17425247.2025.2516668

@article{096294e8ffe147f7b6179e9e028e7af5,

title = "Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications",

keywords = "Biological sciences",

author = "Hana Kadavil and \{Ali Adib\}, Sandi and Alia Marei and Al-Qahtani, \{Noora H.\} and Ying Zhu and Al-Kinani, \{Ali A.\} and Alany, \{Raid G.\} and Younes, \{Husam M.\}",

note = "Note: This work was supported by the Qatar Research, Development \& Innovation (QRDI) National Priorities Research Program (NPRP) [grant \# NPRP13S-0126-200173].",

year = "2025",

month = jun,

day = "9",

doi = "10.1080/17425247.2025.2516668",

language = "English",

journal = "Expert Opinion on Drug Delivery",

issn = "1742-5247",

publisher = "Taylor and Francis Ltd.",

}

Kadavil, H, Ali Adib, S, Marei, A, Al-Qahtani, NH, Zhu, Y, Al-Kinani, AA , Alany, RG & Younes, HM 2025, 'Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications', Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2025.2516668

Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications. / Kadavil, Hana; Ali Adib, Sandi; Marei, Alia et al.
In: Expert Opinion on Drug Delivery, 09.06.2025.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases

T2 - overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications

AU - Kadavil, Hana

AU - Ali Adib, Sandi

AU - Marei, Alia

AU - Al-Qahtani, Noora H.

AU - Zhu, Ying

AU - Al-Kinani, Ali A.

AU - Alany, Raid G.

AU - Younes, Husam M.

N1 - Note: This work was supported by the Qatar Research, Development & Innovation (QRDI) National Priorities Research Program (NPRP) [grant # NPRP13S-0126-200173].

PY - 2025/6/9

Y1 - 2025/6/9

KW - Biological sciences

U2 - 10.1080/17425247.2025.2516668

DO - 10.1080/17425247.2025.2516668

M3 - Article

SN - 1742-5247

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

ER -

Kadavil H, Ali Adib S, Marei A, Al-Qahtani NH, Zhu Y, Al-Kinani AA et al. Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications. Expert Opinion on Drug Delivery. 2025 Jun 9. Epub 2025 Jun 9. doi: 10.1080/17425247.2025.2516668